Dr. Raymond Wong

Division of Haematology, Dept. of Medicine & Therapeuticsof the Chinese University, Hong Kong.

Profile

KOL Interviews

1. How can dabigatran bleeding be effectively managed in the absence of an antidote?

1. 해독제가 부재한 상황에서 어떻게 다비가트란 출혈을 효과적으로 관리할 수 있습니까?

1. Làm thế nào để kiểm soát chứng xuất huyết dabigatran hiệu quả trong trường hợp thiếu thuốc giải?

1. Bagaimana pendarahan dabigatran mampu secara efektif diatasi tanpa adanya antidote?

Subtitles

For Healthcare Professional Use ONLY

X

Dr. Raymond Wong is Honorary Clinical Associate Professor and Head of the Division of Haematology at the Department of Medicine & Therapeutics of the Chinese University of Hong Kong. He is also Consultant in the Department of Medicine and Therapeutics at the Prince of Wales Hospital, Hong Kong.

Dr. Wong received his medical degree from the Chinese University of Hong Kong and completed his training at Prince of Wales Hospital, Hong Kong in Haematology and Haematological Oncology, Internal Medicine and Clinical Pharmacology and Therapeutics. Dr. Wong undertook his Blood and Marrow Transplantation Fellowship training at the MD Anderson Cancer Center, Texas, USA and gained a Doctor of Medicine at the Chinese University of Hong Kong.

Dr. Wong has broad research interests with a special focus on the biological and therapeutic aspects of leukaemias, autoimmune haematological diseases, stem cell transplantation, bleeding and thrombosis. He served as the Chairman of the Hong Kong Association of Blood Transfusion and Haematology from 2004 to 2005. Dr. Wong is the author or co-author of over 100 peer-reviewed articles, published in international journals such as Blood, Circulation, JAMA and the New England Journal of Medicine.